Heparins both unfractionated and low-molecular-weight are associated with some cutaneous complications including hematomas, ecchymosis, erythematous plaques, nodules, skin necrosis, contact dermatitis and urticaria, all occurring more commonly at local subcutaneous injection sites.^[@r1],[@r2]^ First reported at 2006 by Perrinaud *et al,* bullous hemorrhagic dermatosis is a rare cutaneous reaction to heparin in which hemorrhagic intraepidermal bullae appear in areas distant from the heparin injection sites and of which there are less than 20 cases described in the literature. ^[@r1],[@r2]^

We present 5 cases of heparin induced bullous hemorrhagic dermatosis at a site distant from the injection. The characteristics of each patient are detailed in [table 1](#t1){ref-type="table"}. All the patients were male with mean age of 74 years, in treatment with enoxaparin at different doses. Patients 3 and 4 were also taking antiplatelet drugs. The onset of bullae was 8-20 days after the beginning of the heparin therapy and the lesions were asymptomatic in all cases. Biopsy was performed in the 5 cases, showing intraepidermic blister filled with red blood cells, without any signs of vasculitis or vessels thrombosis, and heparin-induced bullous hemorrhagic dermatoses was diagnosed ([Figure 1A](#f1){ref-type="fig"}). Laboratory tests\' results, blood count and coagulation studies were normal. Patients 2, 3, and 4 had pruritic conditions previous to the onset of lesions; therefore they scratched their skin. We observed that these patients presented more lesions and that they were more disseminated than in those patients without pruritus. What is more relevant, in patients 2, 3 and 4 some of the lesions had a linear, Koebner-like, arrangement ([Figure 1B](#f1){ref-type="fig"}). Strikingly, patient 3 developed new lesions on the stitches at the site of biopsy ([Figure 1C](#f1){ref-type="fig"}). Patient 5 had no pruritic condition, but the appearance of the lesions was clearly associated to an occasional scratch on the area. In three of our five cases we maintained the treatment; two of them self-resolved without discontinuation but treatment was changed in patient 2 because new lesions kept appearing, but it also had a complete resolution within few weeks. The reaction to heparin seemed to be retarded as proved by the late onset of the bullae, ranging from 8 to 20 days after the beginning of the heparin therapy. This data is also consistent with the reports previously published.^[@r1],[@r3]^

###### 

Bullous hemorrhagic dermatosis at sites distant from subcutaneous injections of heparin. Clinical features

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient\   Sex    Age   Relevant\              Previous\   Diagnosis for\        Other\           Heparin type\   Latency   Number\     Pruritus/other\    Linear lesions\   Lesion location       Evolution
  number                  comorbidities          use of\     heparin use           anticoagulants   and doses                 of bullae   skin diseases      or Koebner\                             
                                                 heparin                                                                                                     phenomenon                              
  ---------- ------ ----- ---------------------- ----------- --------------------- ---------------- --------------- --------- ----------- ------------------ ----------------- --------------------- ----------------------------------
  1          Male   90    Aortic stenosis        Yes         Aortic valve\         No               Enoxaparin\     8 days    \< 5        No                 No                Ankle and wrist       2 weeks;\
                                                             replacement                            80mg/12h                                                                                         Heparin maintained

  2          Male   65    Cryptogenic\           No          Atrial fibrillation   No               Enoxaparin\     9 days    \> 30       Yes. Renal\        Yes               Lower and\            2 months. After\
                          organizing\                                                               60mg/12h                              insufficiency\                       upper extremities     1 month and\
                          pneumonia                                                                                                       causing pruritus                                           a half change\
                                                                                                                                                                                                     treatment to\
                                                                                                                                                                                                     tinzaparin. Res-olution 2 weeks\
                                                                                                                                                                                                     after.

  3          Male   64    Ischemic\              Yes         Study previous\       Aspirin\         Enoxaparin\     7 days    \> 30       Yes. Xeroderma     Yes               Lower and\            3 weeks;\
                          cardiomyopathy                     to heart\             100mg/d          60mg/12h                                                                   upper extremities     Heparin maintained
                                                             transplantation                                                                                                                         

  4          Male   89    Cardiac\               No          Atrial fibrillation   Aspirin\         Enoxaparin\     10 days   \> 100      Yes. Chronic\      Yes               Lower and\            3 weeks;\
                          decompensation                                           300mg/d          40mg/12h                              urticaria                            upper extremities,\   Heparin suspended
                                                                                                                                                                               scalp and upper\      
                                                                                                                                                                               part of the back      

  5          Male   74    Systemic amyloidosis   Yes         Atrial fibrillation   No               Enoxaparin\     20 days   \< 5        No                 No                Hand and leg          2 weeks;\
                                                                                                    40mg/12h                                                                                         Heparin suspended
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Figure 1Bullous hemorrhagic dermatosis at sites distant from subcutaneous injections of heparin. **A:** Histopathologic findings: subepidermal blister filled with red blood cells. Case 1. **B:** Linear arrangement of the lesions. Case 4. **C**: Koebner phenomenon with development of new lesions on the area in which the stiches were given. Case 3

The pathogenesis of this condition is unclear. Since some patients were receiving high doses of heparin it has been proposed a dose-related reaction.^[@r3]^ In our series only one patient received very high doses of heparin, and two patients received low dose. Other authors also agree with this observation,^[@r4]^ being unlikely an overdose phenomenon. A synergic mechanism has also been proposed for patients treated with one or more anticoagulants or antiplatelet drugs, however, cases also occurred without anticoagulants and with normal coagulation studies.^[@r1],[@r3],[@r4]^ Only two of our patients were taking anticoagulants and coagulation studies were normal in all the cases, therefore we doubt the contribution of theses factors in the development of the bullae. Hypersensitivity reaction to heparin injection has been suggested ^[@r4]^ but the absence of eosinophils on histology does not support this theory. Previous reports also show lesions arranged in groups on small skin areas ^[@r5]^ or showing a linear, Koebner-like, arrangement.^[@r1],[@r4]^ This consistent with the relevance of an external trauma causing or increasing the number of lesions. More recent reports indicate that in most cases discontinuation of the treatment is not necessary.^[@r2],[@r4]^ In the cases in which we decided to maintain treatment the lesions eventually disappeared. However, in one case the lesions where persistent for a month and a half hence treatment was changed with complete resolution afterwards. Therefore if the appearance of new lesions continues for longer than three weeks it should be advisable to change the anticoagulant therapy. Our observations prove an increased number of lesions after trauma. This might not be the only cause but it is for sure an important factor in the development of the bullae, with a significant increase in the number of lesions in patients suffering from pruritic conditions. In fact, disseminated lesions emerged only in these patients. Since Koebner phenomenon occurs in this disease dermatologist should be aware that there can be disseminated and more persistent lesions in patients with pruritic conditions. An individualized approach, taking into account the extension, time of evolution and the importance of anticoagulation in the context of each patient helps to decide whether to suspend, maintain or change therapy.
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